---
title: "Thermo Fisher Scientific Inc. (TMO.US)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/TMO.US.md"
symbol: "TMO.US"
name: "Thermo Fisher Scientific Inc."
industry: "Life Sciences Tools and Services"
datetime: "2026-05-20T06:06:18.924Z"
locales:
  - [en](https://longbridge.com/en/quote/TMO.US.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/TMO.US.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/TMO.US.md)
---

# Thermo Fisher Scientific Inc. (TMO.US)

## Company Overview

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Biopharma Services. The Life Sciences Solutions segment includes reagents, instruments, and consumables for biological and medical research; discovery and production of drugs and vaccines; and diagnosis of infections and diseases.

| Item | Detail |
|------|--------|
| Industry | Life Sciences Tools and Services |
| Exchange | US Market |
| Website | [www.thermofisher.com](https://www.thermofisher.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: C
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-05-20T04:30:13.000Z

**Overall: C (0.44)**

**Industry**: Life Sciences Tools and Services

| Metric | Value |
|--------|-------|
| Industry Ranking | 11 / 59 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Value - Stocks where the company's main business is in a mature stage.
- **Scale**: Large - The company has stable operations, allowing for dependable long-term returns.

**Multi Score**: C

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 5.36% |  |
| Net Profit YoY | 5.13% |  |
| P/B Ratio | 3.20 |  |
| Dividend Ratio | 0.39% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 166415808241.65 |  |
| Revenue | 45197000000.00 |  |

#### Multi Score Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | 13.52% | B |
| Profit Margin | 15.15% | A |
| Gross Margin | 40.38% | B |
| Revenue YoY | 5.36% | C |
| Net Profit YoY | 5.13% | C |
| Total Assets YoY | 14.38% | B |
| Net Assets YoY | 5.21% | C |
| Cash Flow Margin | 121.01% | B |
| OCF YoY | 5.36% | C |
| Turnover | 0.43 | C |
| Gearing Ratio | 54.04% | C |

```chart-data:radar
{
  "title": "Longbridge Financial Score - Thermo Fisher Scientific Inc.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "5.36%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "5.13%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "3.20",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "0.39%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "166415808241.65",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "45197000000.00",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "C",
      "indicators": [
        {
          "name": "ROE",
          "value": "13.52%",
          "rating": "B"
        },
        {
          "name": "Profit Margin",
          "value": "15.15%",
          "rating": "A"
        },
        {
          "name": "Gross Margin",
          "value": "40.38%",
          "rating": "B"
        },
        {
          "name": "Revenue YoY",
          "value": "5.36%",
          "rating": "C"
        },
        {
          "name": "Net Profit YoY",
          "value": "5.13%",
          "rating": "C"
        },
        {
          "name": "Total Assets YoY",
          "value": "14.38%",
          "rating": "B"
        },
        {
          "name": "Net Assets YoY",
          "value": "5.21%",
          "rating": "C"
        },
        {
          "name": "Cash Flow Margin",
          "value": "121.01%",
          "rating": "B"
        },
        {
          "name": "OCF YoY",
          "value": "5.36%",
          "rating": "C"
        },
        {
          "name": "Turnover",
          "value": "0.43",
          "rating": "C"
        },
        {
          "name": "Gearing Ratio",
          "value": "54.04%",
          "rating": "C"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | 24.30 | 8/59 | 32.75 | 28.07 | 25.10 |
| PB | 3.20 | 36/59 | 4.22 | 3.61 | 3.28 |
| PS (TTM) | 3.68 | 31/59 | 4.92 | 4.26 | 3.80 |
| Dividend Yield | 0.39% | 8/59 | 0.38% | 0.34% | 0.30% |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | ChromaDex (CDXC.US) | A | A | A | B | A | A |
| 02 | Agilent Tech (A.US) | A | C | B | C | C | B |
| 03 | West Pharmaceutical (WST.US) | B | B | B | B | B | B |
| 04 | Illumina (ILMN.US) | A | C | B | D | C | B |
| 05 | WuXi Biologics (WXXWY.US) | B | B | C | A | B | B |

## Institutional View

### Analyst Rating Distribution

> As of 2026-05-14T04:00:00.000Z

Total Analysts: **29**

| Rating | Count | Percentage |
|--------|-------|-----------| 
| Buy | 19 | 66% |
| Overweight | 5 | 17% |
| Hold | 3 | 10% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 447.81 |
| Highest Target | 750.00 |
| Lowest Target | 520.00 |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/TMO.US/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/TMO.US/norm.md)
- [Related News](https://longbridge.com/en/quote/TMO.US/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/TMO.US/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**